Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268710
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2005-12-21
Brief Title:
Docetaxel in Hormone Refractory Prostate Cancer HRPCWeekly or 3weekly TAX Prednisone in HRPC
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
XRP6976J_2503
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Affairs Study Director
Old Organization:
sanofi-aventis
Collaborators
| Name | Class |
|---|---|
| Canadian Urologic Oncology Group | OTHER |